StockDriftsStockDriftsDefinium Therapeutics, Inc. has 1 SEC filing in the last 90 days, latest: CEO Robert Barrow sells $721.7K of stock under 10b5-1 plan (4, September 5, 2026). Each filing below is summarised from the document itself and links straight to the original on SEC EDGAR.
Of the 1 filings tracked here, 1 reports an insider sale. See only DFTX Form 4 filings.
CEO Robert Barrow sold 19,023 shares for a total value of $721,732.62, executed under a 10b5-1 trading plan.